Conceivable Life Sciences Raises $50 Million For AI Automation And Robotic Precision In IVF

Conceivable Life Sciences has announced a $50 million Series A round to amplify its work and efforts to bring AI driven automation and advanced robotic precision to the In Vitro Fertilization (IVF) space. The round will be led by numerous prominent investors including ARTIS ventures, Stride and ACME ventures.

Currently, the IVF lifecycle is an incredibly cumbersome and manually driven workflow which depends heavily on human experience, dexterity…